Jasper Therapeutics, Inc.·4

Nov 30, 4:05 PM ET

WIGGANS THOMAS G 4

4 · Jasper Therapeutics, Inc. · Filed Nov 30, 2023

Insider Transaction Report

Form 4
Period: 2023-11-28
Transactions
  • Purchase

    Voting Common Stock

    2023-11-28$0.65/sh+10,000$6,48650,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6311 to $0.669, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Documents

1 file
  • 4
    ownership.xmlPrimary